GENNIEFY
Market News
Latest financial news and analysis from global markets
HD
Home Depot Earnings Beat As Mortgage Rates Climb To 9-Month High
Home Depot earnings fell less than views, but same-store sales missed. Home-improvement rival Lowe's is due Wednesday. The stocks are ailing.
BAC
US Yields Near 2007 Highs Entice and Divide Investors
(Bloomberg) -- A surge in longer-maturity US Treasury yields is testing the resolve of global bond investors torn between the possibility of locking in the rates near to the highest levels in decades and the risk of an even greater selloff.Most Read from BloombergUS Lawmakers Plan New $130 Fee for Electric Vehicle OwnersBillionaire Rinehart Bets $100 Million on US Defense StocksTrump Says Holding Off on New Iran Strikes After Gulf AppealStocks and Oil Whipsaw on Mixed US-Iran Signals: Markets Wr
NVDA
Should You Buy the Dip on Nike Stock?
The world's top athleticwear company is struggling.
INTC
Should You Buy the Dip on Nike Stock?
The world's top athleticwear company is struggling.
NKE
Should You Buy the Dip on Nike Stock?
The world's top athleticwear company is struggling.
REGN
Why Regeneron Pharmaceuticals (REGN) Is Down 11.7% After Key Melanoma Combo Trial Missed Its Goal
Earlier in May 2026, Regeneron Pharmaceuticals reported that its Phase 3 trial of fianlimab plus cemiplimab in first-line unresectable or metastatic melanoma failed to achieve statistically significant improvement in progression-free survival versus pembrolizumab, although no new safety issues emerged. This trial miss has already prompted legal scrutiny of Regeneron’s leadership and intensified concerns about the company’s oncology pipeline and future revenue mix. We’ll now examine how...
JPM
How The Phreesia (PHR) Narrative Is Shifting With Slower Ad Growth And Tougher Competition
Phreesia’s central fair value estimate has been trimmed from about US$16.17 to US$15.39, a reduction of roughly 4.8% that reflects a more cautious stance on the stock. This reset is consistent with recent analyst commentary pointing to slower digital advertising trends, tougher competition, and a wave of price target cuts and rating changes across the street. As you read on, you will see how to track these shifting views and what to watch as the narrative around Phreesia continues to...
XAU/USD
Blossom Gold Provides Two Rosebud Project Updates
Blossom Gold (BGAU.TO) said on Tuesday that all initially planned metallurgical drill holes at its R
AVGO
3 Incredible AI Stocks That Aren't Too Late to Buy Now
The long-term trajectory of AI spending will drive this trio higher.
NVDA
3 Incredible AI Stocks That Aren't Too Late to Buy Now
The long-term trajectory of AI spending will drive this trio higher.
NVDA
Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More
Pre-Market Stock Futures: Futures are trading lower on Tuesday as the sell-off in technology stocks carried through to Monday and is headed down that road today. All of the major indices, except the Dow Jones Industrial Average, which closed 0.32% higher at 49,668, finished the day lower. The small-cap Russell 2000 was the big loser ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-
BAC
Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More
Pre-Market Stock Futures: Futures are trading lower on Tuesday as the sell-off in technology stocks carried through to Monday and is headed down that road today. All of the major indices, except the Dow Jones Industrial Average, which closed 0.32% higher at 49,668, finished the day lower. The small-cap Russell 2000 was the big loser ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-